Caxton Associates (New York)’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,143	Closed	-$93K	–	475
2020 Q1	$93K	Buy	+12,143	New	+$93K	0.02%	385